Identification of a Folate Receptor-Targeted Near-Infrared Molecular Contrast Agent to Localize Pulmonary Adenocarcinomas

Abstract excerpt

Non-small cell lung cancer (NSCLC) is the number one cancer killer in the United States. Despite attempted curative surgical resection, nearly 40% of patients succumb to recurrent disease. High recurrence rates may be partially explained by data suggesting that 20% of NSCLC patients harbor synchronous disease that is missed during resection. In this report, we describe the use of a novel folate receptor-targeted...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hepatocellular Carcinoma Treatment and Prognosis
• Share to Lung Cancer Diagnosis and Treatment
• Share to Nanoplatforms for cancer theranostics